0001209191-21-067491.txt : 20211202
0001209191-21-067491.hdr.sgml : 20211202
20211202141659
ACCESSION NUMBER: 0001209191-21-067491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lecault Veronique
CENTRAL INDEX KEY: 0001834418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211466012
MAIL ADDRESS:
STREET 1: C/O ABCELLERA BIOLOGICS INC.
STREET 2: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-30
0
0001703057
AbCellera Biologics Inc.
ABCL
0001834418
Lecault Veronique
C/O ABCELLERA BIOLOGICS INC.
2215 YUKON STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
1
1
0
0
Chief Operating Officer
Common Shares
2021-11-30
4
M
0
83333
14.96
A
1422666
D
Common Shares
7155008
I
See Footnote
Common Shares
273630
I
See Footnote
Common Shares
61580
I
By spouse
Share Option (right to buy)
0.19
2021-11-30
4
M
0
83333
0.00
D
2027-03-23
Common Shares
83333
2774134
D
These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive
power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her
indirect pecuniary interest therein.
These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial
ownership of such securities, except to the extent of her indirect pecuniary interest therein.
The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Tryn Stimart, attorney-in-fact
2021-12-02